Recombinant multi-species Apelin/APLN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Apelin/APLN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a peptide that functions as an endogenous ligand for the G-protein coupled apelin receptor. The encoded preproprotein is proteolytically processed into biologically active C-terminal peptide fragments. These peptide fragments activate different tissue specific signaling pathways that regulate diverse biological functions including fluid homeostasis, cardiovascular function and insulin secretion. This protein also functions as a coreceptor for the human immunodeficiency virus 1. [provided by RefSeq, Feb 2016]
The Alternative Names of target: 6030430G11Rik,APEL,APJ endogenous ligand,APLN,Apel,Apelin,Apln,XNPEP2
Go
to Apelin/APLN products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T58674-Ag-1/ GM-Tg-hg-T58674-Ag-2 | Human Apelin/APLN protein | Human |
| GM-Tg-rg-T58674-Ag-1/ GM-Tg-rg-T58674-Ag-2 | Rat Apelin/APLN protein | Rat |
| GM-Tg-mg-T58674-Ag-1/ GM-Tg-mg-T58674-Ag-2 | Mouse Apelin/APLN protein | Mouse |
| GM-Tg-cynog-T58674-Ag-1/ GM-Tg-cynog-T58674-Ag-2 | Cynomolgus/Rhesus macaque Apelin/APLN protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T58674-Ag-1/ GM-Tg-felg-T58674-Ag-2 | Feline Apelin/APLN protein | Feline |
| GM-Tg-cang-T58674-Ag-1/ GM-Tg-cang-T58674-Ag-2 | Canine Apelin/APLN protein | Canine |
| GM-Tg-bovg-T58674-Ag-1/ GM-Tg-bovg-T58674-Ag-2 | Bovine Apelin/APLN protein | Bovine |
| GM-Tg-equg-T58674-Ag-1/ GM-Tg-equg-T58674-Ag-2 | Equine Apelin/APLN protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T58674-Ag-1/ GM-Tg-hg-T58674-Ag-2;
GM-Tg-rg-T58674-Ag-1/ GM-Tg-rg-T58674-Ag-2;
GM-Tg-mg-T58674-Ag-1/ GM-Tg-mg-T58674-Ag-2; GM-Tg-cynog-T58674-Ag-1/ GM-Tg-cynog-T58674-Ag-2; GM-Tg-felg-T58674-Ag-1/ GM-Tg-felg-T58674-Ag-2; GM-Tg-cang-T58674-Ag-1/ GM-Tg-cang-T58674-Ag-2; GM-Tg-bovg-T58674-Ag-1/ GM-Tg-bovg-T58674-Ag-2; GM-Tg-equg-T58674-Ag-1/ GM-Tg-equg-T58674-Ag-2 |
| Products Name | Apelin/APLN protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | Apelin/APLN |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Apelin/APLN protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.